Prevention and management of chronic non-communicable diseases in children and young people (GACD)
Funding for implementation research focused on the prevention, risk reduction, diagnosis, and management of chronic non-communicable diseases (NCDs) in children and young people (ages 1–24) in low- and middle-income countries (LMICs) or underserved populations in high-income countries (HICs). Targets researchers, policymakers, and healthcare providers aiming to improve equitable access to evidence-based interventions.
Details
Agency
EU Commission
Status
Open
Language
English
Funding Type
Grant
Funding Amount
Up to 11.0M €
Deadline
2027-04-13
Open Date
2027-02-10
Overview
Funding for implementation research focused on the prevention, risk reduction, diagnosis, and management of chronic non-communicable diseases (NCDs) in children and young people (ages 1–24) in low- and middle-income countries (LMICs) or underserved populations in high-income countries (HICs). Targets researchers, policymakers, and healthcare providers aiming to improve equitable access to evidence-based interventions.Who Can Apply
Consortia of legal entities, including research institutions, universities, healthcare providers, public health authorities, and non-governmental organizations. Projects must demonstrate equitable partnerships between HIC and LMIC institutions or between non-Indigenous and Indigenous team members. Early career researchers must be included as co-investigators.Funding Details
- Maximum grant amount: €11,000,000
- Funding rate: Not specified (lump-sum funding model)
- Total budget: Not specified
- Co-funding: Not required but sustainability beyond the project lifespan must be demonstrated
What Is Funded
Implementation research on evidence-based interventions for:- Policy evaluation addressing social, economic, political, or commercial determinants of NCDs in children/young people
- Prevention strategies (e.g., educational, vaccination, behavioral/lifestyle changes)
- Screening and diagnosis (including digital tools)
- Cost-effective, patient-centered management (e.g., access to medicines, integrated care pathways, caregiver support)
- Adaptation and scaling of interventions for local, regional, or national contexts
- Focus on chronic NCDs (e.g., mental health disorders, autoimmune conditions, neurological disorders) or risk factors
Technology / Maturity Requirements
- Proposals must focus on implementation research (not feasibility, etiological, or efficacy studies)
- Interventions must have existing evidence of effectiveness, cost-effectiveness, sustainability, and scalability
- Use of established implementation research frameworks (e.g., CFIR, RE-AIM, PRISM) or hybrid designs combining effectiveness and implementation outcomes
- Formative research may be included to support readiness for implementation
Key Dates
- Open date: 2027-02-09
- Deadline: 2027-04-12T22:00:00Z
Application Process (High-Level)
- Single-stage submission via the [Funding & Tenders Portal](https://ec.europa.eu/info/funding-tenders/opportunities/portal)
- Requires a detailed application form (HE RIA/IA) and annexes, including a template for clinical studies if applicable
- Evaluation based on excellence, impact, and implementation criteria (thresholds: 4/5 per criterion, cumulative 12/15)
Post-Award Obligations
- Participation in GACD networking activities (e.g., annual scientific meetings, joint workshops)
- Dissemination of results to policymakers, communities, and practitioners
- Reporting on implementation outcomes, real-world effectiveness, and sustainability plans
- Engagement with stakeholders for post-funding intervention sustainability
- Capacity-building for early career researchers and team members from LMICs or disadvantaged communities
Geographic Scope & Language
- Eligible countries: LMICs (as defined by the World Bank) and underserved populations in HICs, including Indigenous communities. Open to legal entities in the EU, associated countries, and the USA (specific provisions apply).
- Language: English
Notes
- Proposals must include a stakeholder engagement strategy with evidence of support from key actors.
- Exclusions: Standalone feasibility projects, epidemiological cohorts, etiological/mechanistic research, clinical trials for pharmacological/behavioral interventions, or validation studies.
- Social sciences and humanities (SSH) expertise must be integrated to address societal determinants of health.
- Lump-sum funding model: Costs are pre-defined; no detailed financial reporting required post-award.
- Equity focus: Interventions must address health disparities and may target specific populations (e.g., gender, racial/ethnic groups) with justification.